Published in Cell Immunol on April 15, 1994
Natural health products, modulation of immune function and prevention of chronic diseases. Evid Based Complement Alternat Med (2005) 1.51
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population. Aging Dis (2011) 1.23
The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev (2013) 1.01
Reciprocal age related change in natural killer cell receptors for MHC class I. Mech Ageing Dev (2005) 0.97
Natural killer cell cytotoxicity in elderly humans after influenza immunization. Clin Diagn Lab Immunol (1996) 0.90
NK cell compartment in patients with coronary heart disease. Immun Ageing (2007) 0.87
The host environment is responsible for aging-related functional NK cell deficiency. J Immunol (2013) 0.83
Kidney transplantation and the ageing immune system. Nat Rev Nephrol (2012) 0.76
Tissue detection of natural killer cells in colorectal adenocarcinoma. BMC Gastroenterol (2004) 0.76
Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane. Anesthesiology (1993) 1.92
Immune response to influenza vaccination in a large healthy elderly population. Vaccine (1999) 1.41
Immunologic response in an elderly population with a mean age of 85. Am J Med (1986) 1.22
Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing. J Immunol (1985) 1.20
Cytokine production after influenza vaccination in a healthy elderly population. Vaccine (1998) 1.11
Effect of interferon on thoracic duct lymphocyte output: induction with either poly I:poly C or vaccinia virus. J Immunol (1983) 1.04
Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population. Vaccine (2001) 1.04
Inhibition of macrophage-induced antigen-specific T-cell proliferation by interferon-gamma. Cell Immunol (1988) 1.02
Splenic and inguinal lymph node T cells of aged mice respond differently to polyclonal and antigen-specific stimuli. Cell Immunol (1992) 0.91
Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma. Cancer Res (1991) 0.91
Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes. J Neuroimmunol (1988) 0.90
Natural killer cell cytotoxicity in elderly humans after influenza immunization. Clin Diagn Lab Immunol (1996) 0.90
Genetic variation in the ability of several strains of rats to produce interferon in response to polyriboinosinic-polyribocytodilic acid. Infect Immun (1984) 0.86
Immune response to influenza vaccine in healthy elderly: lack of association with plasma beta-carotene, retinol, alpha-tocopherol, or zinc. Mech Ageing Dev (2000) 0.85
Apparent lack of H-2 restriction of allograft rejection. J Immunol (1978) 0.85
Age-associated decline in IL-2 and IL-12 induction of LAK cell activity of human PBMC samples. Mech Ageing Dev (1996) 0.85
Interferon-gamma, interferon-alpha/beta, and tumor necrosis factor differentially affect major histocompatibility complex class I expression in murine leukemia virus-induced tumor cell lines. J Immunol (1987) 0.85
Anesthesia inhibits interferon-induced natural killer cell cytotoxicity via induction of CD8+ suppressor cells. Cell Immunol (1993) 0.84
Expression of MHC class I genes in mouse hepatitis virus (MHV-A59) infection and in multiple sclerosis. Adv Exp Med Biol (1987) 0.83
Detection of specific surface antigens on cells transformed by cytomegalovirus with the techniques of mixed hemagglutination and 125I-labeled antiglobulin. J Immunol (1974) 0.83
Monocyte culture and adherence modifies LPS-induced IL-6 production and inhibition by hydrocortisone. Clin Immunol Immunopathol (1994) 0.83
The role of vitamin A in natural killer cell cytotoxicity, number and activation in the rat. Nat Immun (1994) 0.82
Age-related changes in interferon-alpha/beta receptor expression, binding, and induction of apoptosis in natural killer cells from C57BL/6 mice. Mech Ageing Dev (2000) 0.82
Induction of natural killer cell activity of thoracic duct lymphocytes by polyinosinic-polycytidylic acid (poly(I:C)) or interferon. Cell Immunol (1985) 0.82
Poly I:C or IFN-alpha/beta treatment inhibits macrophage induced T cell proliferation. J Interferon Res (1985) 0.82
Inhibition of lymphocyte recirculation by murine interferon: effects of various interferon preparations and timing of administration. J Interferon Res (1989) 0.82
The effects of general anesthesia and surgery on basal and interferon stimulated natural killer cell activity of humans. Anesth Analg (1997) 0.81
Genetic differences in the age-associated decrease in inducibility of natural killer cells by interferon-alpha/beta. Mech Ageing Dev (2000) 0.81
Cytotoxic and morphologic profile of endogenous and pyrimidinone-activated murine NK cells. J Immunol (1986) 0.81
Heterogeneous effects of exogenous lymphokines on lymphoproliferation of elderly subjects. Mech Ageing Dev (1991) 0.80
Cellular immune response to virus-specific antigen in hamsters bearing isografts of cytomegalovirus-transformed cells. Int J Cancer (1974) 0.80
Basal natural killer cell activity of young versus elderly humans. J Gerontol A Biol Sci Med Sci (1995) 0.80
A murine leukemia virus expressed in aged DBA/2 mice is derived by recombination of the Emv-3 locus and another endogenous gag sequence. Virology (1994) 0.80
Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus. J Natl Cancer Inst (1978) 0.79
The age-associated decline in immune function of healthy individuals is not related to changes in plasma concentrations of beta-carotene, retinol, alpha-tocopherol or zinc. Mech Ageing Dev (1997) 0.79
T-kininogen is a biomarker of senescence in rats. Mech Ageing Dev (1998) 0.78
Varying role of alpha/beta interferon in the antiviral efficacy of synthetic immunomodulators against Semliki Forest virus infection. Antiviral Res (1991) 0.78
Inhibition of macrophage-induced antigen-specific T lymphocyte proliferation by poly I:C: strain and antigen independence. Cell Immunol (1991) 0.78
Prolonged E55+ retrovirus expression in aged mice is associated with a decline in the anti-virus immune response. Virology (2001) 0.78
Neoadjuvant immunotherapy with interferon of the spontaneously metastasizing murine B16F10L melanoma. Int J Cancer (1990) 0.78
The role of T cell phenotypes in decreased lymphoproliferation of the elderly. Clin Immunol Immunopathol (1989) 0.78
Age associated changes in mitogen induced proliferation and cytokine production by lymphocytes of the long-lived brown Norway rat. Mech Ageing Dev (1993) 0.77
Maintenance of normal T lymphocyte function after transfection with SV40 large T. Cell Immunol (1993) 0.77
Effect of age on cytokine production in humans. Age (Omaha) (1998) 0.77
Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes. Ann N Y Acad Sci (1988) 0.77
Inhibition of macrophage-induced, antigen-specific T-cell proliferation by poly I:C role of suppressor macrophages. Immunology (1994) 0.77
Extension of lifespan of human T lymphocytes by transfection with SV40 large T antigen. Exp Cell Res (1992) 0.77
Anesthesia inhibits poly I:C induced stimulation of natural killer cell cytotoxicity in mice. Clin Immunol Immunopathol (1990) 0.76
Inhibition of induction of natural killer activity in mice by general anesthesia (Avertin): role of interferon. Clin Immunol Immunopathol (1991) 0.76
Hydrocortisone regulation of interleukin-6 protein production by a purified population of human peripheral blood monocytes. Clin Immunol Immunopathol (1993) 0.76
Age-associated changes in mitogen-induced lymphoproliferation and lymphokine production in the long-lived brown-Norway rat: effect of caloric restriction. Mech Ageing Dev (1995) 0.76
Induction of interferon in AKR mice by murine leukaemia viruses. Nature (1980) 0.76
Ultrastructural study of biochemically modulated ADCC in HSV-1 infected and uninfected Chang liver cells. Microbios (1986) 0.75
A replication-competent, endogenous retrovirus from an aged DBA/2 mouse contains the complete env from Emv-3 and a novel gag partially related to AKT-8. J Virol (1995) 0.75
Effect of the mixed bacterial vaccine on the immune response of patients with non-small cell lung cancer and refractory malignancies. Cancer (1988) 0.75
Interferon-induced inhibition of lymphocyte circulation: lack of effect on humoral immune responses to T-dependent or T-independent antigens. J Interferon Res (1988) 0.75
Ultrastructure of antibody dependent cellular cytotoxicity in HSV 1 infected and uninfected Chang liver cells. Cytobios (1986) 0.75
Enhancement or inhibition of tumor growth by interferon: dependence on treatment protocol. Int J Cancer (1983) 0.75
Production, screening and characterization of a monoclonal antibody to murine interferon-beta. J Gen Virol (1983) 0.75
Biological similarities of rat fibroblast interferon to human and mouse alpha interferons. J Gen Virol (1985) 0.75
Interferon-induced inhibition of Moloney sarcoma virus-transformed cells: requirement for T-cells. Cancer Res (1989) 0.75
Immunostimulation of cytomegalovirus-transformed cells and its inhibition by blocking sera. J Natl Cancer Inst (1976) 0.75
Genetic control of neutralizing antibody response to mouse interferon in rats. J Interferon Res (1984) 0.75
Role of natural killer cells in the mechanism of the antitumor effect of interferon on Moloney sarcoma virus-transformed cells. Cancer Res (1986) 0.75
Effect of exogenous cytokines on the inhibition of macrophage-induced, antigen-specific T cell proliferation by poly(I:C). Clin Immunol Immunopathol (1992) 0.75
Transplacental interferon-mediated effect in AKR mice. Virology (1980) 0.75
Effect of anti-interferon serum on Friend virus infection and Fv-1-mediated resistance. J Interferon Res (1981) 0.75
Immunological studies with hamster cells transformed by cytomegalovirus and herpes simplex virus type 1. IARC Sci Publ (1975) 0.75
Differences between young and aged mice in susceptibility to Friend virus. Mech Ageing Dev (1994) 0.75
Spleen-cell cytotoxicity for cytomegalovirus-transformed cells. II. Inhibition by cytomegalovirus antiserum. Int J Cancer (1975) 0.75
Effect of antibody to interferon on genital herpesvirus infection in mice. Microb Pathog (1986) 0.75
Production and partial purification of rat fibroblast-derived interferon induced in a newly established cell line. J Interferon Res (1984) 0.75